Verily

Verily (formerly Google Life Sciences) is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 2015, when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet. Verily has developed continuous glucose monitors, surgical robotics, and contact lenses for people with diabetes.